![Calvin Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Calvin Yu worked as Senior Director-Finance & SEC Reporting at Adverum Biotechnologies, Inc. from 2014 to 2016.
Prior to that, he worked as Controller at Five Prime Therapeutics, Inc. from 2010 to 2014.
He also worked as Controller at Stemcentrx, Inc. from 2016 to 2017.
Currently, he is the Chief Financial & Accounting Officer at Alector, Inc. Mr. Yu completed his undergraduate degree from San Francisco State University.
Anciens postes connus de Calvin Yu
| Sociétés | Poste | Fin |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Comptroller/Controller/Auditor | 01/06/2017 |
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur Financier/CFO | 01/02/2016 |
| FIVE PRIME THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/09/2014 |
| ALECTOR, INC. | Directeur Financier/CFO | 08/09/2021 |
Formation de Calvin Yu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
